Use of Pre-Infusion Serum Uric Acid Levels as a Biomarker for Infusion Reaction Risk in Patients on Pegloticase
Crossref DOI link: https://doi.org/10.1007/s40744-019-0151-9
Published Online: 2019-03-14
Published Print: 2019-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Keenan, Robert T.
Baraf, Herbert S. B.
LaMoreaux, Brian http://orcid.org/0000-0001-7521-241X
Funding for this research was provided by:
Horizon Pharma
Article History
Received: 11 February 2019
First Online: 14 March 2019